STAT3-IN-3  ≥98%

促销价¥{{model.attbuying.price}}

市场价¥0.00

累计销量0 累计评价0 人评论

别称 {{model.alias}}
中文名称 {{model.name}}
英文名称 {{model.enname}}
品牌 {{model.brand}}
CAS {{model.cas}}
分子式
分子量 {{model.molecularweight}}
MDL {{model.mdl}}
货号 {{model.procode}}
数量

+ -

库存{{model.attbuying.number}}
包装规格:5mg in glass bottle
溶解性:溶于DMSO(5 mg/mL 超声)
产品描述:基本信息 产品编号: S10694 产品名称: STAT3-IN-3 CAS: 2361304-26-7   储存条件 粉末 -20℃ 四年     分子式: C27H26BrN3O6S 溶于液体 -80℃ 6个月 分子量: 600.48 -20℃ 1个月 化学名:  3-(4-(4-Bromo-1,1-dioxidocinnamoyl)piperazine-1-carbonyl)-7-(diethylamino)-2H-chromen-2-one Solubility (25°C):   体外:   DMSO   Ethanol   Water   体内(现配现用):   <1mg/ml表示微溶或不溶。 普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。   制备储备液   浓度   溶液体积 质量   1mg   5mg   10mg 1mM 1.6653mL 8.3267mL 16.6533mL 5mM 0.3331mL 1.6653mL 3.3307mL   生物活性 产品描述 一种有效和选择性的STAT3抑制剂,有抗增殖活性。 靶点 STAT3   体外研究 induce mitochondrial apoptotic pathway.STAT3-IN-3 (1-4μM;24 hours) can induce the cleavage of caspase-9,caspase-3 and PARP.STAT3-IN-3 has no influence on the phosphorylation levels of STAT1,JAK2,Src and Erk1/2.STAT3-IN-3 inhibits the growth of MDA-MB-231,HCT-116,HepG2,and MCF-7 cells with IC50s of 1.43μM,1.89μM,2.88μM,and 3.33μM,respectively.STAT3-IN-3 down-regulates the expression of STAT3 target genes Bcl-2 and Cyclin D1.STAT3-IN-3 inhibits STAT3 tyrosine phosphorylation and serine phosphorylation.STAT3-IN-3 inhibits STAT3 DNA-binding activity.STAT3-IN-3 (1-4μM;24 hours) increases ROS production and remarkably reduces the mitochondrial membrane potential to. Cell Viability Assay Cell Line: MDA-MB-231 cells,HCT-116 cells,HepG2 cells,MCF-7cells Concentration: MTT assay Incubation Time: 48 hours Result: Exhibited anti-proliferative activity. Apoptosis Analysis Cell Line: MDA-MB-231 cells Concentration: 0μM,1μM,2μM,4μM Incubation Time: 24 hours Result: Induced the apoptosis of MDA-MB-231 cells dose-dependently and the apoptosis rates. Western Blot Analysis Cell Line: MDA-MB-231 cells Concentration: 0μM,1μM,2μM,4μM Incubation Time: 24 hours Result: Induced the cleavage of caspase-9,caspase-3 and PARP. 体内研究 STAT3-IN-3 (10mg/kg-20mg/kg; i.p.;daily;for 14 days) possesses potent antitumor activity against implanted 4T1 breast tumors growth. Animal Model: Adult female BALB/c mice (6 weeks of age) Dosage: 10mg/kg,20mg/kg Administration: Intraperitoneal injection,daily,for 14 days Result: Significantly inhibited tumor volume.
保存条件:-20℃